CD8A and glioblastoma: Flow cell analysis of clinical GBM biopsy samples have shown that T cells account for only 0.25% of the GBM tumor of which CD8+ cytotoxic T cells, which are the effector killer T cells, account for only one-fourth of the total CD3+T cell population.